Related Experiment Video

Updated: Nov 8, 2025

In vitro Organoid Culture of Primary Mouse Colon Tumors
07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

35.5K

SPOCK1 promotes the proliferation and migration of colon cancer cells by regulating the NF-κB pathway and inducing

Han-Xiong Liu1, Yuan-Yuan Cao2, Jia-Yao Qu3

  • 1Department of Gastroenterology, The First People's Hospital of Chenzhou, Chenzhou, China.

Neoplasma
|April 22, 2021
PubMed

Insights

Sparc/osteonectin, cwcv, and kazal-like domains proteoglycan 1 (SPOCK1) promotes colon cancer (CRC) cell proliferation and migration. SPOCK1 may activate NF-κB/Snail signaling, serving as a prognostic indicator and therapeutic target for CRC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Sparc/osteonectin, cwcv, and kazal-like domains proteoglycan 1 (SPOCK1) is implicated in various cancers.
  • Its specific role in colon cancer (CRC) requires further elucidation.

Purpose of the Study:

  • To investigate the impact of SPOCK1 on CRC cell proliferation, migration, and epithelial-mesenchymal transition (EMT).
  • To explore SPOCK1's correlation with CRC patient prognosis.

Main Methods:

  • Analysis of SPOCK1 expression in CRC datasets.
  • SPOCK1 overexpression and knockdown in HCT-116 and SW480 cells.
  • CCK-8 and Transwell assays for proliferation and migration.
  • Western blotting for NF-κB and EMT-related proteins.

Main Results:

  • SPOCK1 mRNA levels are elevated in CRC tissues and negatively correlate with patient prognosis.
  • SPOCK1 overexpression enhances CRC cell proliferation and migration; knockdown reduces these effects.
  • SPOCK1 influences NF-κB and EMT-related protein expression.

Conclusions:

  • SPOCK1 promotes CRC cell proliferation and migration, potentially via the NF-κB/Snail pathway.
  • SPOCK1 represents a potential prognostic biomarker and therapeutic target for CRC.

More Related Videos

Induction and Analysis of Epithelial to Mesenchymal Transition10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

36.2K
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.2K

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K